Prostate Cancer Market Report

Global Prostate Cancer Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 12, 2022
  • PAGES：193
  • REPORT CODE：GMM814054
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Prostate Cancer market report explains the definition, types, applications, major countries, and major players of the Prostate Cancer market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Sanofi SA

    • Johnson & Johnson

    • Bayer AG

    • AstraZeneca plc

    • Bristol Myers Squibb (BMS)

    • Astellas Inc

    By Type:

    • Hormone sensitive prostate cancer

    • Hormone refractory prostate cancer

    By End-User:

    • Chemotherapy

    • Hormonal Therapy

    • Targeted Therapy

    • Immunotherapy

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Prostate Cancer Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Prostate Cancer Outlook to 2028- Original Forecasts

    • 2.2 Prostate Cancer Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Prostate Cancer Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Prostate Cancer Market- Recent Developments

    • 6.1 Prostate Cancer Market News and Developments

    • 6.2 Prostate Cancer Market Deals Landscape

    7 Prostate Cancer Raw Materials and Cost Structure Analysis

    • 7.1 Prostate Cancer Key Raw Materials

    • 7.2 Prostate Cancer Price Trend of Key Raw Materials

    • 7.3 Prostate Cancer Key Suppliers of Raw Materials

    • 7.4 Prostate Cancer Market Concentration Rate of Raw Materials

    • 7.5 Prostate Cancer Cost Structure Analysis

      • 7.5.1 Prostate Cancer Raw Materials Analysis

      • 7.5.2 Prostate Cancer Labor Cost Analysis

      • 7.5.3 Prostate Cancer Manufacturing Expenses Analysis

    8 Global Prostate Cancer Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Prostate Cancer Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Prostate Cancer Export by Region (Top 10 Countries) (2017-2028)

    9 Global Prostate Cancer Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormone sensitive prostate cancer Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hormone refractory prostate cancer Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Immunotherapy Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Prostate Cancer Market Analysis and Outlook till 2022

    • 10.1 Global Prostate Cancer Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Prostate Cancer Consumption (2017-2022)

      • 10.2.2 Canada Prostate Cancer Consumption (2017-2022)

      • 10.2.3 Mexico Prostate Cancer Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Prostate Cancer Consumption (2017-2022)

      • 10.3.2 UK Prostate Cancer Consumption (2017-2022)

      • 10.3.3 Spain Prostate Cancer Consumption (2017-2022)

      • 10.3.4 Belgium Prostate Cancer Consumption (2017-2022)

      • 10.3.5 France Prostate Cancer Consumption (2017-2022)

      • 10.3.6 Italy Prostate Cancer Consumption (2017-2022)

      • 10.3.7 Denmark Prostate Cancer Consumption (2017-2022)

      • 10.3.8 Finland Prostate Cancer Consumption (2017-2022)

      • 10.3.9 Norway Prostate Cancer Consumption (2017-2022)

      • 10.3.10 Sweden Prostate Cancer Consumption (2017-2022)

      • 10.3.11 Poland Prostate Cancer Consumption (2017-2022)

      • 10.3.12 Russia Prostate Cancer Consumption (2017-2022)

      • 10.3.13 Turkey Prostate Cancer Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Prostate Cancer Consumption (2017-2022)

      • 10.4.2 Japan Prostate Cancer Consumption (2017-2022)

      • 10.4.3 India Prostate Cancer Consumption (2017-2022)

      • 10.4.4 South Korea Prostate Cancer Consumption (2017-2022)

      • 10.4.5 Pakistan Prostate Cancer Consumption (2017-2022)

      • 10.4.6 Bangladesh Prostate Cancer Consumption (2017-2022)

      • 10.4.7 Indonesia Prostate Cancer Consumption (2017-2022)

      • 10.4.8 Thailand Prostate Cancer Consumption (2017-2022)

      • 10.4.9 Singapore Prostate Cancer Consumption (2017-2022)

      • 10.4.10 Malaysia Prostate Cancer Consumption (2017-2022)

      • 10.4.11 Philippines Prostate Cancer Consumption (2017-2022)

      • 10.4.12 Vietnam Prostate Cancer Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Prostate Cancer Consumption (2017-2022)

      • 10.5.2 Colombia Prostate Cancer Consumption (2017-2022)

      • 10.5.3 Chile Prostate Cancer Consumption (2017-2022)

      • 10.5.4 Argentina Prostate Cancer Consumption (2017-2022)

      • 10.5.5 Venezuela Prostate Cancer Consumption (2017-2022)

      • 10.5.6 Peru Prostate Cancer Consumption (2017-2022)

      • 10.5.7 Puerto Rico Prostate Cancer Consumption (2017-2022)

      • 10.5.8 Ecuador Prostate Cancer Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Prostate Cancer Consumption (2017-2022)

      • 10.6.2 Kuwait Prostate Cancer Consumption (2017-2022)

      • 10.6.3 Oman Prostate Cancer Consumption (2017-2022)

      • 10.6.4 Qatar Prostate Cancer Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Prostate Cancer Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Prostate Cancer Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Prostate Cancer Consumption (2017-2022)

      • 10.7.2 South Africa Prostate Cancer Consumption (2017-2022)

      • 10.7.3 Egypt Prostate Cancer Consumption (2017-2022)

      • 10.7.4 Algeria Prostate Cancer Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Prostate Cancer Consumption (2017-2022)

      • 10.8.2 New Zealand Prostate Cancer Consumption (2017-2022)

    11 Global Prostate Cancer Competitive Analysis

    • 11.1 Sanofi SA

      • 11.1.1 Sanofi SA Company Details

      • 11.1.2 Sanofi SA Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Sanofi SA Prostate Cancer Main Business and Markets Served

      • 11.1.4 Sanofi SA Prostate Cancer Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Johnson & Johnson

      • 11.2.1 Johnson & Johnson Company Details

      • 11.2.2 Johnson & Johnson Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Johnson & Johnson Prostate Cancer Main Business and Markets Served

      • 11.2.4 Johnson & Johnson Prostate Cancer Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bayer AG

      • 11.3.1 Bayer AG Company Details

      • 11.3.2 Bayer AG Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bayer AG Prostate Cancer Main Business and Markets Served

      • 11.3.4 Bayer AG Prostate Cancer Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 AstraZeneca plc

      • 11.4.1 AstraZeneca plc Company Details

      • 11.4.2 AstraZeneca plc Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 AstraZeneca plc Prostate Cancer Main Business and Markets Served

      • 11.4.4 AstraZeneca plc Prostate Cancer Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bristol Myers Squibb (BMS)

      • 11.5.1 Bristol Myers Squibb (BMS) Company Details

      • 11.5.2 Bristol Myers Squibb (BMS) Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Main Business and Markets Served

      • 11.5.4 Bristol Myers Squibb (BMS) Prostate Cancer Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Astellas Inc

      • 11.6.1 Astellas Inc Company Details

      • 11.6.2 Astellas Inc Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Astellas Inc Prostate Cancer Main Business and Markets Served

      • 11.6.4 Astellas Inc Prostate Cancer Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    12 Global Prostate Cancer Market Outlook by Types and Applications to 2028

    • 12.1 Global Prostate Cancer Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Hormone sensitive prostate cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Hormone refractory prostate cancer Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Prostate Cancer Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Prostate Cancer Market Analysis and Outlook to 2028

    • 13.1 Global Prostate Cancer Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Prostate Cancer Consumption Forecast (2022-2028)

      • 13.2.2 Canada Prostate Cancer Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Prostate Cancer Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.2 UK Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.3 Spain Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.5 France Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.6 Italy Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.8 Finland Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.9 Norway Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.11 Poland Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.12 Russia Prostate Cancer Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Prostate Cancer Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.2 Japan Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.3 India Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Prostate Cancer Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Prostate Cancer Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.3 Chile Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.6 Peru Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Prostate Cancer Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Prostate Cancer Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Prostate Cancer Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Prostate Cancer Consumption Forecast (2022-2028)

      • 13.6.3 Oman Prostate Cancer Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Prostate Cancer Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Prostate Cancer Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Prostate Cancer Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Prostate Cancer Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Prostate Cancer Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Prostate Cancer Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Prostate Cancer Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Prostate Cancer Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Prostate Cancer Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Prostate Cancer

    • Figure of Prostate Cancer Picture

    • Table Global Prostate Cancer Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Prostate Cancer Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Hormone sensitive prostate cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone refractory prostate cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption by Country (2017-2022)

    • Table North America Prostate Cancer Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Canada Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Mexico Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Consumption by Country (2017-2022)

    • Figure Germany Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure UK Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Spain Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Belgium Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure France Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Italy Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Denmark Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Finland Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Norway Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Sweden Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Poland Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Russia Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Turkey Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table APAC Prostate Cancer Consumption by Country (2017-2022)

    • Figure China Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Thailand Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Singapore Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Philippines Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table South America Prostate Cancer Consumption by Country (2017-2022)

    • Figure Brazil Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Colombia Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Chile Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Argentina Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Peru Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table GCC Prostate Cancer Consumption by Country (2017-2022)

    • Figure Bahrain Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Oman Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Qatar Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table Africa Prostate Cancer Consumption by Country (2017-2022)

    • Figure Nigeria Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Africa Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Egypt Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Algeria Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table Oceania Prostate Cancer Consumption by Country (2017-2022)

    • Figure Australia Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Table Sanofi SA Company Details

    • Table Sanofi SA Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Prostate Cancer Main Business and Markets Served

    • Table Sanofi SA Prostate Cancer Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Prostate Cancer Main Business and Markets Served

    • Table Johnson & Johnson Prostate Cancer Product Portfolio

    • Table Bayer AG Company Details

    • Table Bayer AG Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Prostate Cancer Main Business and Markets Served

    • Table Bayer AG Prostate Cancer Product Portfolio

    • Table AstraZeneca plc Company Details

    • Table AstraZeneca plc Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Prostate Cancer Main Business and Markets Served

    • Table AstraZeneca plc Prostate Cancer Product Portfolio

    • Table Bristol Myers Squibb (BMS) Company Details

    • Table Bristol Myers Squibb (BMS) Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb (BMS) Prostate Cancer Main Business and Markets Served

    • Table Bristol Myers Squibb (BMS) Prostate Cancer Product Portfolio

    • Table Astellas Inc Company Details

    • Table Astellas Inc Prostate Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Inc Prostate Cancer Main Business and Markets Served

    • Table Astellas Inc Prostate Cancer Product Portfolio

    • Figure Global Hormone sensitive prostate cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone refractory prostate cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Table North America Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure Germany Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure China Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure Brazil Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Prostate Cancer Consumption Forecast by Country (2022-2028)

    • Figure Australia Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US